EquityLK
All analyses
AI analysis

Lanka Hospitals Corp. Plc: research report

LHCLView stock page →
Moderately undervaluedneutralAug 7, 2026

Net profit jumped 49% YoY in March; the dividend runs at a 138% payout, so sustainability is the question.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why balanced

  • Net profit rose 49.1% YoY in the March quarter on an 11.5% operating margin.
  • Balance sheet resilience, with interest cover at 36.0x and a 4.15 current ratio, limits downside from financing and working capital.

Against this. The payout is 137.5% with dividend cover of 0.73, so the 11.7% yield leans on distributions above earnings.

Operating margin
10.4%sector 14.5%
from 12.5% a year earlier
Net margin
18.8%sector 10.9%
from 12.5% a year earlier, revenue +7.0%
Return on equity
14.6%
twelve months to Jun 30, 2026, unaudited
P/E
10.8sector 10.8
earnings Rs 10.66 per share
P/B
1.57sector 1.41
book Rs 73.19 per share
Dividend yield
2.61%sector 0.00%
28.1% of earnings paid out

Current figures, updated daily from filings to Jun 30, 2026. The report below was written on Aug 7, 2026. Sector figures are the median of 6 listed companies in the same sector.

Overview

Lanka Hospitals runs a 367-bed multi-speciality tertiary hospital with accredited diagnostics and pharmacy operations in Sri Lanka. The latest filings show earnings momentum improving with wider operating profitability, while board roles were refreshed during the period.

Price performance

As of 2026-08-07 the share closed at LKR 111. It fell 9.0% over one month versus the ASPI’s -2.1%, but is up 30.6% over one year versus 9.5% for the index. The price sits around 68% of its 52-week range, in the upper half.

Valuation

Multiples are close to healthcare-sector norms: P/E 11.74 and P/B 1.62, supported by a 12.7% ROE. The headline dividend yield is 11.7%. By financial year the payout has been rising, from LKR 1.5 per share in FY2024 to LKR 3.0 in FY2025. Yield sustainability is discussed under Risks.

News and sentiment

Coverage has been about normal: 5 material articles in 90 days, all neutral. Confirmed actions include a final dividend of LKR 1.00 per share (ex 2026-06-03) and board changes (Chairman and Group MD roles). A trading halt on 2026-05-22 preceded these disclosures.

Financials

March-quarter revenue grew 11.9% YoY, with operating margin widening by 2.3 points to 11.5% and net margin at 13.4%. Net profit rose 49.1% YoY, helped by below-the-line items that added LKR 72.9 million.

For FY2025, profit growth was strong, with net profit up 45.2% and margins in the low-to-mid teens, indicating better cost control and throughput.

Risks

The key risk is dividend sustainability: the payout is 137.5% and dividend cover 0.73, indicating distributions above earnings. Secondary risks include trading liquidity being quieter than usual, with 20-day volume 48.3% below the 60-day pace. Profit quality shows some sensitivity to below-the-line items; the latest quarter benefited by LKR 72.9 million. Mitigants include robust financing headroom (interest cover 36.0x) and strong liquidity (current ratio 4.15).

Outlook

As at 2026-08-07 the next results (period end 2026-06-30) are due now and expected by 2026-10-26. That update will show whether margin gains persist and how the board frames dividends relative to earnings. Easing local rates should modestly support financing costs, albeit from already low levels.

About this report. Generated on Aug 7, 2026 from market data up to Aug 7, 2026, 5 material news articles over 90 days and financials to Mar 31, 2026. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports

Aug 16, 2026Aug 7, 2026